Alpha Core Capital LLC Acelrx Pharmaceuticals Inc Transaction History

Alpha Core Capital LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$1.03 - $1.69 $5,350 - $8,779	-5,195 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.76 - $2.07 $3,948 - $10,753	5,195 New	5,195 $6,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Core Capital LLC with notifications on news.